Pulmonary Manifestations of Primary Immunodeficiency Disorders

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Pulmonary disease, ranging from infectious pneumonia, lung abscess, and empyema to structural lung diseases to malignancy, significantly increase morbidity and mortality in primary immune deficiency. Treatment with supplemental immunoglobulin (intravenous or subcutaneous) and antimicrobials is beneficial in reducing infections but are largely ineffective in preventing noninfectious complications, including interstitial lung disease, malignancy, and autoimmune disease. A low threshold for suspecting pulmonary complications is necessary for the early diagnosis of pulmonary involvement in primary immunodeficiency disorders, before irreversible damage is done, to improve patient outcomes.

Original languageEnglish (US)
Pages (from-to)753-766
Number of pages14
JournalImmunology and Allergy Clinics of North America
Volume35
Issue number4
DOIs
StatePublished - Nov 1 2015

Fingerprint

Lung Diseases
Lung Abscess
Lung
Empyema
Intravenous Immunoglobulins
Interstitial Lung Diseases
Autoimmune Diseases
Early Diagnosis
Neoplasms
Pneumonia
Morbidity
Mortality
Infection
Therapeutics

Keywords

  • Bronchiectasis
  • Common variable immune deficiency
  • Interstitial lung disease
  • Primary immunodeficiency disease
  • Pulmonary complication

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Pulmonary Manifestations of Primary Immunodeficiency Disorders. / Nonas, Stephanie.

In: Immunology and Allergy Clinics of North America, Vol. 35, No. 4, 01.11.2015, p. 753-766.

Research output: Contribution to journalArticle

@article{a711c7b1522242d79e869094243ce873,
title = "Pulmonary Manifestations of Primary Immunodeficiency Disorders",
abstract = "Pulmonary disease, ranging from infectious pneumonia, lung abscess, and empyema to structural lung diseases to malignancy, significantly increase morbidity and mortality in primary immune deficiency. Treatment with supplemental immunoglobulin (intravenous or subcutaneous) and antimicrobials is beneficial in reducing infections but are largely ineffective in preventing noninfectious complications, including interstitial lung disease, malignancy, and autoimmune disease. A low threshold for suspecting pulmonary complications is necessary for the early diagnosis of pulmonary involvement in primary immunodeficiency disorders, before irreversible damage is done, to improve patient outcomes.",
keywords = "Bronchiectasis, Common variable immune deficiency, Interstitial lung disease, Primary immunodeficiency disease, Pulmonary complication",
author = "Stephanie Nonas",
year = "2015",
month = "11",
day = "1",
doi = "10.1016/j.iac.2015.07.004",
language = "English (US)",
volume = "35",
pages = "753--766",
journal = "Immunology and Allergy Clinics of North America",
issn = "0889-8561",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Pulmonary Manifestations of Primary Immunodeficiency Disorders

AU - Nonas, Stephanie

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Pulmonary disease, ranging from infectious pneumonia, lung abscess, and empyema to structural lung diseases to malignancy, significantly increase morbidity and mortality in primary immune deficiency. Treatment with supplemental immunoglobulin (intravenous or subcutaneous) and antimicrobials is beneficial in reducing infections but are largely ineffective in preventing noninfectious complications, including interstitial lung disease, malignancy, and autoimmune disease. A low threshold for suspecting pulmonary complications is necessary for the early diagnosis of pulmonary involvement in primary immunodeficiency disorders, before irreversible damage is done, to improve patient outcomes.

AB - Pulmonary disease, ranging from infectious pneumonia, lung abscess, and empyema to structural lung diseases to malignancy, significantly increase morbidity and mortality in primary immune deficiency. Treatment with supplemental immunoglobulin (intravenous or subcutaneous) and antimicrobials is beneficial in reducing infections but are largely ineffective in preventing noninfectious complications, including interstitial lung disease, malignancy, and autoimmune disease. A low threshold for suspecting pulmonary complications is necessary for the early diagnosis of pulmonary involvement in primary immunodeficiency disorders, before irreversible damage is done, to improve patient outcomes.

KW - Bronchiectasis

KW - Common variable immune deficiency

KW - Interstitial lung disease

KW - Primary immunodeficiency disease

KW - Pulmonary complication

UR - http://www.scopus.com/inward/record.url?scp=84943819838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943819838&partnerID=8YFLogxK

U2 - 10.1016/j.iac.2015.07.004

DO - 10.1016/j.iac.2015.07.004

M3 - Article

VL - 35

SP - 753

EP - 766

JO - Immunology and Allergy Clinics of North America

JF - Immunology and Allergy Clinics of North America

SN - 0889-8561

IS - 4

ER -